PRINCIPAL FINANCIAL GROUP INC - ANTARES PHARMA INC ownership

ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 177 filers reported holding ANTARES PHARMA INC in Q1 2022. The put-call ratio across all filers is 0.08 and the average weighting 0.1%.

Quarter-by-quarter ownership
PRINCIPAL FINANCIAL GROUP INC ownership history of ANTARES PHARMA INC
ValueSharesWeighting
Q1 2022$406,000
-13.4%
99,106
-24.7%
0.00%
Q4 2021$469,000
+269.3%
131,560
+275.8%
0.00%
Q3 2021$127,000
+9.5%
35,007
+31.2%
0.00%
Q2 2021$116,000
-21.6%
26,690
-25.7%
0.00%
Q1 2021$148,000
-10.8%
35,936
-13.6%
0.00%
Q4 2020$166,000
+4.4%
41,614
-29.4%
0.00%
Q3 2020$159,000
-7.0%
58,926
-5.0%
0.00%
Q2 2020$171,000
+210.9%
61,998
+165.1%
0.00%
Q1 2020$55,000
-49.5%
23,391
+0.4%
0.00%
Q4 2019$109,000
-52.4%
23,289
-66.0%
0.00%
Q3 2019$229,000
+14.5%
68,411
+12.7%
0.00%
Q2 2019$200,000
+5.8%
60,709
-3.0%
0.00%
Q1 2019$189,000
+10.5%
62,601
-0.5%
0.00%
Q4 2018$171,000
-23.3%
62,940
-4.9%
0.00%
Q3 2018$223,000
+45.8%
66,175
+11.6%
0.00%
Q2 2018$153,000
-11.0%
59,316
-24.1%
0.00%
Q1 2018$172,000
+13.2%
78,104
+1.9%
0.00%
Q4 2017$152,000
+90.0%
76,650
+209.3%
0.00%
Q3 2017$80,000
-5.9%
24,784
-5.8%
0.00%
Q2 2017$85,000
+183.3%
26,298
-23.5%
0.00%
Q1 2016$30,000
-21.1%
34,386
+10.2%
0.00%
Q4 2015$38,000
-22.4%
31,207
+7.7%
0.00%
Q3 2015$49,000
-44.9%
28,970
-32.1%
0.00%
Q2 2015$89,000
-4.3%
42,654
+23.8%
0.00%
Q1 2015$93,000
-8.8%
34,441
-9.7%
0.00%
Q2 2014$102,000
-49.0%
38,142
-33.2%
0.00%
Q1 2014$200,000
-9.5%
57,131
+5.2%
0.00%
Q3 2013$221,00054,3180.00%
Other shareholders
ANTARES PHARMA INC shareholders Q1 2022
NameSharesValueWeighting ↓
Healthcare Value Capital, LLC 500,000$2,180,0004.34%
FIRST WILSHIRE SECURITIES MANAGEMENT INC 2,535,727$11,056,0003.87%
Sargent Investment Group, LLC 3,596,250$15,680,0003.72%
Rubric Capital Management LP 9,500,000$41,420,0002.61%
PERKINS CAPITAL MANAGEMENT INC 541,783$2,362,0001.34%
ORACLE INVESTMENT MANAGEMENT INC 1,900,000$8,284,0001.14%
Venator Capital Management Ltd. 709,700$3,094,0001.05%
LEVEL FOUR FINANCIAL, LLC 120,000$523,0000.22%
OBERWEIS ASSET MANAGEMENT INC/ 200,600$875,0000.19%
Brown Advisory Securities, LLC 275,000$1,199,0000.19%
View complete list of ANTARES PHARMA INC shareholders